Association Between Serum Afamin Levels with Nonalcoholic Associated Fatty Liver Disease

Table 1

Clinical characteristics of NAFLD patients and healthy controls.

Variables	Healthy controls (n = 88)	NAFLD patients (n = 88)	value
Age (years)	47.85 ± 12.86	47.64 ± 13.94	0.804^a
Gender (female/male)	32/56	32/56	1.000^b
Body mass index (kg/m^2)	23.04 ± 2.22	26.3 ± 2.53	<0.001^a
Waist circumference (cm)	80.03 ± 6.15	87.37 ± 12.31	<0.001^a
Systolic blood pressure (mm Hg)	123.2 ± 18.75	128.68 ± 24.56	0.098^a
Diastolic blood pressure (mm Hg)	74.06 ± 11.99	77.43 ± 11.92	0.063^a
Alanine aminotransferase (U/L)	22.61 ± 21.91	42.65 ± 57.38	0.003^a
Aspartate aminotransferase (U/L)	21.06 ± 11.4	28.7 ± 35.77	0.058^a
γ-Glutamyl transpeptidase (U/L)	29.92 ± 26.39	44.97 ± 36.91	0.002^a
Uric acid (μmol/L)	331.24 ± 71.39	373.6 ± 89.62	0.001^a
Triglyceride (mmol/L)	1.43 ± 1.06	2.27 ± 1.75	<0.001^a
Total cholesterol (mmol/L)	4.70 ± 0.92	4.89 ± 1.02	0.201^a
High-density lipoprotein cholesterol (mmol/L)	1.27 ± 0.30	1.12 ± 0.27	<0.001^a
Low-density lipoprotein cholesterol (mmol/L)	2.73 ± 0.78	2.83 ± 0.78	0.441^a
Fast blood glucose (mmol/L)	5.25 ± 1.51	5.43 ± 1.32	0.415^a
Afamin (mg/L)	10.83 ± 3.24	14.79 ± 5.04	<0.001^a

Data are expressed as the means ± standard deviations. ^a Student’s t-test. ^b Pearson chi-square test.